Clustered,
regularly interspaced short palindromic repeats (CRISPR)-based
diagnoses, derived from gene-editing technology, have been exploited
for less than 5 years and are now reaching the stage of precommercial
use. CRISPR tools have some notable features, such as recognition
at physiological temperature, excellent specificity, and high-efficiency
signal amplification capabilities. These characteristics are promising
for the development of next-generation diagnostic technologies. In
this Perspective, we present a detailed summary of which micro/nanotechnologies
play roles in the advancement of CRISPR diagnosis and how they are
involved. The use of nanoprobes, nanochips, and nanodevices, microfluidic
technology, lateral flow strips, etc. in CRISPR detection
systems has led to new opportunities for CRISPR-based diagnosis assay
development, such as achieving equipment-free detection, providing
more compact detection systems, and improving sensitivity and quantitative
capabilities. Although tremendous progress has been made, CRISPR diagnosis
has not yet reached its full potential. We discuss upcoming opportunities
and improvements and how micro/nanotechnologies will continue to play
key roles.